Immunomedics halts late-stage clinical trial, confirming drug benefit for aggressive type of breast cancer. (STAT Plus)

More reads

• Immunomedics halts late-stage clinical trial, confirming drug benefit for aggressive type of breast cancer. (STAT Plus)
• Deerfield raises $840 million for new health care venture fund. (Bloomberg)
• Fact-checking Trump’s claims about hydroxychloroquine, the antimalarial drug he’s touting as a coronavirus treatment. (STAT)
• GlaxoSmithKline and Vir aim to take on Covid-19 with antibodies and CRISPR. (STAT)